Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

121 studies match

clinicaltrialsPublishedShowing 1–50 of 121 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04613596	Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7	recruiting	Phase 2 / Phase 3	626	Mirati Therapeutics Inc.INDUSTRY	47	Sep 16, 2026	clinicaltrials
NCT03407144	Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)	active not recruiting	Phase 2	340	Merck Sharp & Dohme LLCINDUSTRY	16	Sep 15, 2026